• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外循环期间单核细胞组织因子表达、细胞活化及凝血酶形成:一项临床研究

Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.

作者信息

Ernofsson M, Thelin S, Siegbahn A

机构信息

Department of Clinical Chemistry, University Hospital, Uppsala, Sweden.

出版信息

J Thorac Cardiovasc Surg. 1997 Mar;113(3):576-84. doi: 10.1016/S0022-5223(97)70373-8.

DOI:10.1016/S0022-5223(97)70373-8
PMID:9081105
Abstract

OBJECTIVES

Cardiopulmonary bypass is associated with extensive thrombin generation and cell activation. Our main hypothesis in this study was that the expression of tissue factor on circulating monocytes contributes to the formation of thrombin.

METHODS

Markers of activation of the coagulation cascade and cell activation were measured in 26 patients undergoing elective heart operations randomized to the use of heparin-coated (Duraflo II, n = 13) or standard cardiopulmonary bypass circuits (n = 13).

RESULTS

Thrombin generation, measured as the thrombin-antithrombin complex, increased considerably during cardiopulmonary bypass with peak levels 3 hours afterward and with remaining elevation 20 hours later. Despite increased monocyte and granulocyte activation and increased levels of monocyte chemotactic protein-1, which upregulates monocyte tissue factor expression in vitro, monocyte tissue factor expression was not increased at the end of cardiopulmonary bypass. Furthermore, at this time the monocytes were less sensitive to in vitro stimulation by endotoxin. These results might be explained by simultaneous enhanced levels of interleukin-10, which effectively downregulates monocyte tissue factor expression in vitro. Twenty hours after cardiopulmonary bypass was discontinued, the tissue factor expression on freshly isolated monocytes and on monocytes stimulated by endotoxin was significantly increased compared with preoperative levels. At this time increased activation markers of granulocytes, monocytes, and lymphocytes were also recorded. None of the measured parameters was found to be different between the groups.

CONCLUSIONS

The tissue factor expression on circulating monocytes is upregulated the day after heart operations. The clinical relevance and the regulatory mechanism behind the enhanced expression, however, are not fully elucidated.

摘要

目的

体外循环与广泛的凝血酶生成及细胞活化有关。本研究的主要假设是循环单核细胞上组织因子的表达有助于凝血酶的形成。

方法

在26例行择期心脏手术的患者中,测量凝血级联反应激活和细胞活化的标志物,这些患者被随机分为使用肝素涂层(Duraflo II,n = 13)或标准体外循环回路(n = 13)。

结果

以凝血酶 - 抗凝血酶复合物衡量的凝血酶生成在体外循环期间显著增加,术后3小时达到峰值水平,20小时后仍有升高。尽管单核细胞和粒细胞活化增加,且单核细胞趋化蛋白 - 1水平升高,后者在体外可上调单核细胞组织因子表达,但体外循环结束时单核细胞组织因子表达并未增加。此外,此时单核细胞对内毒素的体外刺激敏感性降低。这些结果可能由白细胞介素 - 10水平同时升高来解释,白细胞介素 - 10在体外可有效下调单核细胞组织因子表达。体外循环停止20小时后,与术前水平相比,新鲜分离的单核细胞以及经内毒素刺激的单核细胞上的组织因子表达显著增加。此时还记录到粒细胞、单核细胞和淋巴细胞的活化标志物增加。两组间未发现任何测量参数存在差异。

结论

心脏手术后次日循环单核细胞上的组织因子表达上调。然而,这种增强表达背后的临床相关性和调节机制尚未完全阐明。

相似文献

1
Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.体外循环期间单核细胞组织因子表达、细胞活化及凝血酶形成:一项临床研究
J Thorac Cardiovasc Surg. 1997 Mar;113(3):576-84. doi: 10.1016/S0022-5223(97)70373-8.
2
Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.肝素涂层体外循环回路的生物相容性:一项随机、盲法临床试验。
J Thorac Cardiovasc Surg. 1996 Aug;112(2):472-83. doi: 10.1016/S0022-5223(96)70275-1.
3
Early heparin administration attenuates tissue factor-mediated thrombin generation during simulated cardiopulmonary bypass.早期给予肝素可减轻体外循环模拟过程中组织因子介导的凝血酶生成。
J Card Surg. 2014 Jan;29(1):35-40. doi: 10.1111/jocs.12254. Epub 2013 Nov 25.
4
Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.使用Duraflo II肝素涂层体外循环设备对血小板功能及凝血/纤溶的临床研究
ASAIO J. 1996 Jul-Aug;42(4):301-5.
5
Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.血浆组织因子加活化的外周血单个核细胞激活心脏手术伤口处的因子VII和因子X。
J Am Coll Cardiol. 2005 Aug 16;46(4):707-13. doi: 10.1016/j.jacc.2005.05.040.
6
Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.使用肝素涂层或标准回路进行体外循环期间的凝血酶生成。
Scand J Thorac Cardiovasc Surg. 1995;29(4):157-65. doi: 10.3109/14017439509107224.
7
Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.关于体外循环期间凝血酶生成机制的另一种观点:组织因子途径抑制物的作用。
J Cardiothorac Vasc Anesth. 2001 Feb;15(1):60-4. doi: 10.1053/jcan.2001.20278.
8
Formation of tissue factor-bearing leukocytes during and after cardiopulmonary bypass.
Thromb Haemost. 2004 Jul;92(1):124-31. doi: 10.1160/TH03-12-0787.
9
Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.闭合式体外循环回路可抑制冠状动脉搭桥手术期间的凝血酶生成。
Interact Cardiovasc Thorac Surg. 2010 Apr;10(4):555-60. doi: 10.1510/icvts.2009.214437. Epub 2010 Jan 8.
10
Direct activation of factor X by monocytes occurs during cardiopulmonary bypass.单核细胞对凝血因子X的直接激活发生在体外循环期间。
Br J Haematol. 1998 Apr;101(1):40-6. doi: 10.1046/j.1365-2141.1998.00674.x.

引用本文的文献

1
Factor eight inhibitor bypassing activity for refractory bleeding in coronary artery bypass grafting: A propensity-matched analysis.冠状动脉搭桥术中用于难治性出血的凝血因子Ⅷ抑制剂旁路活性:一项倾向匹配分析。
Res Pract Thromb Haemost. 2022 Dec 2;6(8):e12838. doi: 10.1002/rth2.12838. eCollection 2022 Nov.
2
[Tissue factors and venous thromboembolism in cancer patients].[癌症患者的组织因子与静脉血栓栓塞]
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Dec 25;49(6):772-778. doi: 10.3785/j.issn.1008-9292.2020.12.13.
3
Extracorporeal life support and systemic inflammation.
体外生命支持与全身炎症反应
Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):46. doi: 10.1186/s40635-019-0249-y.
4
Platelets protect lung from injury induced by systemic inflammatory response.血小板可保护肺部免受全身炎症反应引起的损伤。
Sci Rep. 2017 Feb 3;7:42080. doi: 10.1038/srep42080.
5
Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations.血小板与重组活化因子VII联合使用以增强急性A型夹层手术期间的止血效果。
J Cardiothorac Surg. 2014 Sep 2;9:156. doi: 10.1186/s13019-014-0156-y.
6
Recombinant factor VII is associated with worse survival in complex cardiac surgical patients.重组凝血因子VII与复杂心脏手术患者较差的生存率相关。
Ann Thorac Surg. 2014 Aug;98(2):618-24. doi: 10.1016/j.athoracsur.2014.04.126. Epub 2014 Jun 24.
7
The prophylactic use of recombinant factor VIIa in a patient with DeBakey type III aortic dissection -A case report-.采用重组 VII 因子预防治疗 DeBakey Ⅲ型主动脉夹层-病例报告-。
Korean J Anesthesiol. 2011 Nov;61(5):431-4. doi: 10.4097/kjae.2011.61.5.431. Epub 2011 Nov 23.
8
High mortality associated with intracardiac and intrapulmonary thromboses after cardiopulmonary bypass.体外循环后心内和肺内血栓形成与高死亡率相关。
J Anesth. 2012 Feb;26(1):9-19. doi: 10.1007/s00540-011-1253-x. Epub 2011 Oct 19.
9
Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass.体外循环中的凝血和纤溶蛋白动力学
J Thromb Thrombolysis. 2009 Jan;27(1):95-104. doi: 10.1007/s11239-007-0187-5. Epub 2008 Jan 23.
10
Children undergoing cardiac surgery for complex cardiac defects show imbalance between pro- and anti-thrombotic activity.因复杂心脏缺陷接受心脏手术的儿童表现出促血栓形成和抗血栓形成活性之间的失衡。
Crit Care. 2006;10(6):R165. doi: 10.1186/cc5108.